Stockholm - Free Realtime Quote SEK

Acarix AB (publ) (ACARIX.ST)

0.3230

+0.0035

(+1.10%)

As of 4:06 PM GMT+1. Market Open.

Acarix Expands U.S. Reimbursement Coverage for CADScor System for use in Emergency and Outpatient Settings

Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announced today that the U.S. Centers for Medicare & Medicaid Services (CMS) has decided that the CPT code 0716T - the CADScor® System - shall be assigned to APC 5733 including status indicator assignment to "S" (separately payable) for calendar year 2025. The CMS ruling means standalone fixed reimbursement is now possible for the CADScor System in outpatient settings.

PR Newswire 15 days ago

ACIXF
Acarix AB (publ) publishes Interim Report, April - June 2024

Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the second quarter of 2024. The company achieved record-breaking patch sales and record-breaking gross profit, driven by the success of its new sales model coupled with key strategic initiatives involving commercial expansion and clinical activities. These results highlight the company's growing market presence and commitment to innovation in the cardiac diagnostics space.

PR Newswire 2 months ago

ACIXF
Acarix expands within US wellness exam market

Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announces expanded use of the CADScor System within wellness exams as part of self-insured companies' health plans. As healthcare costs continue to rise, the CADScor System has now been proven to be an easy and quick strategy to risk stratify patients for significant coronary artery disease.

PR Newswire 3 months ago

ACIXF
Acarix Announces Shares Are Now Being Traded on the OTCQB Under the Ticker ACIXF

VANCOUVER, BC / ACCESSWIRE / July 30, 2024 / Acarix CEO Aamir Mahmood joined Steve Darling from Proactive to share news the company has begun trading on the OTCQB Market in the United States, under the ticker symbol ACIXF. This listing complements ...

ACCESSWIRE 3 months ago

ACIXF
Acarix Shares Begin Trading on the US-based OTCQB Market

Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce that the Acarix shares (OTCQB: ACIXF) begin trading today on the OTCQB Market in the US. Acarix´s shares will in parallel to its current Nasdaq First North Growth market listing in Stockholm, be traded with a US ticker symbol and a share price in USD.

PR Newswire 4 months ago

ACIXF
Acarix announces the initiation of the first US-based clinical workflow evaluation study

Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the initiation of the first US-based clinical study to collect real-world data to compare workflows between traditional stress tests and the CADScor System. The focus is on identifying non-obstructive Coronary Artery Disease (CAD) in chest pain patients, with the ultimate goal of improving discharge from Emergency Departments and Clinics in the United States.

PR Newswire 7 months ago

ACIXF
New Health Economic Analysis Presented at ACC Highlights the Acarix CADScor System's Cost-Effectiveness

Acarix, a leader in acoustic-based Cardiac Diagnostics, is pleased to announce the results from a 2024 American College of Cardiology (ACC) poster presentation by Suzanne Baron, MD, MSc, Director of Interventional Cardiology Research, Massachusetts General Hospital and Faculty at The Baim Institute for Clinical Research, to assess the cost-utility of the CADScor System for the evaluation of coronary artery disease (CAD) in a low-risk patient population presenting to the Emergency Department (ED)

PR Newswire 7 months ago

ACIXF
Acarix Strengthens U.S. Team with Three Key Advisors

Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the appointment of three new advisors to its team. Joining the advisory board are Ken Nelson, known for his leadership in the MedTech space; Dr. Saumil R. Oza, MD, an experienced electrophysiologist from Ascension Medical Group; and Dave Braun, a strategic and customer-driven executive with over 40 years of experience working in startup and large company environments.

PR Newswire 8 months ago

ACIXF
Acarix CADScor System Now Listed on U.S. VA Federal Supply Schedule

Acarix, a leader in advanced acoustic-based cardiac diagnostic devices today announces the CADScor® System has been added to the United States Federal Supply Schedule (FSS). The nationwide contract simplifies purchasing for the Veterans Health Administration and other federal agencies to efficiently source the CADScor System.

PR Newswire 9 months ago

ACIXF

Performance Overview

Return	ACARIX.ST	OMX Stockholm 30 Index
YTD	+70.18%	+3.55%
1-Year	+43.56%	+12.94%
3-Year	-53.18%	+4.65%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Acarix AB (publ) (ACARIX.ST)

Acarix Expands U.S. Reimbursement Coverage for CADScor System for use in Emergency and Outpatient Settings

Acarix AB (publ) publishes Interim Report, April - June 2024

Acarix expands within US wellness exam market

Acarix Announces Shares Are Now Being Traded on the OTCQB Under the Ticker ACIXF

Acarix Shares Begin Trading on the US-based OTCQB Market

Acarix announces the initiation of the first US-based clinical workflow evaluation study

New Health Economic Analysis Presented at ACC Highlights the Acarix CADScor System's Cost-Effectiveness

Acarix Strengthens U.S. Team with Three Key Advisors

Acarix CADScor System Now Listed on U.S. VA Federal Supply Schedule

Performance Overview